Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 272 No 7289 p269
6 March 2004

This article
Reprint
Photocopy


News summary


IT development integral to pharmacy’s future

IT will be an integral part of practice in the future, said Lindsay McClure, head of information services, Pharmaceutical Services Negotiating Committee, at the local pharmaceutical committee representatives’ conference held this week in London. “It is important that community pharmacists get to grips with the terminology and what is happening.”

Many IT developments will happen relatively soon. Implementation of the electronic transfer of prescriptions, for example, is in the first phase of the NHS Care Records Service and is due to start in 2005. A difficulty currently facing pharmacy system suppliers is that they will be asked to supply new systems quickly but that the specifications for these systems are still unclear, commented Ms McClure. Specifications are expected within the next six to nine months. The Government will also consult shortly on another aspect of NHS Care Records Service — pharmacist access to patient records.

An IT sub committee has been set up by the PSNC, NHS Confederation and Department of Health in order to feed information into the new contract negotiations. It is examining hardware and software requirements, connectivity and the transitional arrangements that will be needed while the IT is being introduced. Work is also under way to assess what will be required in order to connect pharmacies to N3, the new national network that is replacing NHSnet.

What is clear is that funding to upgrade pharmacists’ IT will not be granted in the same way as it is for GPs. “Pharmacy is not in the remit of the local service providers,” said Ms McClure. In other words, although primary care trusts are responsible for provision of IT to doctors, the same will not apply to community pharmacists. “Pharmacy has been specifically excluded from that,” said Sue Sharpe, PSNC chief executive. “Funding will be negotiated through the new contract.”

Asked whether pharmacists would be held to ransom over connection to N3, ie, that they would have to pay for connection in order to meet the new contract, Mrs Sharpe said she thought not. Discussions to date indicated that there would be a one-off payment for initial connection of pharmacies to N3, she confirmed.

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal